Inovio Pharmaceuticals Ownership | Who Owns Inovio Pharmaceuticals?


OverviewForecastFinancialsChartTranscripts

Inovio Pharmaceuticals Ownership Summary


Inovio Pharmaceuticals is owned by 4.94% institutional investors, 0.33% insiders, and 94.73% retail investors. Vanguard group is the largest institutional shareholder, holding 6.36% of INO shares. Fidelity Small Cap Growth is the top mutual fund, with 6.85% of its assets in Inovio Pharmaceuticals shares.

INO Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockInovio Pharmaceuticals4.94%0.33%94.73%
SectorHealthcare Stocks 50.50%12.33%37.17%
IndustryBiotech Stocks 49.09%12.06%38.85%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group3.32M6.36%$5.77M
Fmr8.45M1.22%$9.30M
Janus henderson group3.31M0.71%$5.77M
Vanguard capital management3.65M0.53%$4.02M
Boxer capital management2.84M0.41%$3.13M
Adar1 capital management2.14M0.31%$2.36M
Two sigma advisers, lp108.70K0.28%$254.36K
D. e. shaw1.35M0.20%$1.49M
Stonepine capital management1.35M0.19%$210.18K
Two sigma investments, lp1.24M0.18%$1.36M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Boxer capital management2.84M0.24%$3.13M
Adar1 capital management2.14M0.11%$2.36M
Stonepine capital management1.35M0.10%$210.18K
Eversept partners, lp1.04M0.06%$1.14M
Green alpha advisors68.06K0.05%$74.86K
Gsa capital partners llp265.01K0.02%$292.00K
Gmt capital126.12K0.01%$138.73K
Headlands29.89K0.00%$32.88K
Covestor5.12K0.00%$6.00K
Bridgeway capital management173.00K0.00%$190.30K

Top Buyers

HolderShares% AssetsChange
Stonepine capital management1.35M0.10%1.35M
Two sigma investments, lp1.24M0.00%849.39K
Vanguard capital management3.65M0.00%749.35K
Adar1 capital management2.14M0.11%673.80K
Vanguard group3.32M0.00%602.71K

Top Sellers

HolderShares% AssetsChange
Deep track capital, lp---1.98M
Fmr8.45M0.00%-884.82K
D. e. shaw1.35M0.00%-861.16K
Adage capital partners gp---804.96K
Aigh capital management---654.12K

New Positions

HolderShares% AssetsChangeValue
Stonepine capital management1.35M0.10%1.35M$210.18K
Caption management478.95K0.00%478.95K$526.85K
Nomura150.00K0.00%150.00K$165.00K
Dz bank ag deutsche zentral genossenschafts bank, frankfurt am main133.65K0.00%133.65K$147.01K
Two sigma advisers, lp108.70K0.00%108.70K$254.36K

Sold Out

HolderChange
Ameritas advisory services-2.00
Hm payson-2.00
Sachetta-3.00
Johnson financial group-4.00
S&t bank/pa-4.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20261124.67%34,155,3368.90%423.99%5537.50%16-20.00%
Mar 31, 202655-48.11%4,340,403-86.86%-0.02%16-62.79%9-62.50%
Dec 31, 202567-35.58%6,818,031-67.10%130.46%21-58.82%15-31.82%
Sep 30, 202599-1.00%20,701,614120.05%539.08%498.89%20-25.93%
Jun 30, 2025106-1.85%10,167,785-25.24%262.11%47-9.62%293.57%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Small Cap Growth5.63M6.85%-
Fidelity Small Cap Growth K62.82M3.43%-
Vanguard Morn Total Stk Mkt Idx Investor2.60M3.16%-
Vanguard Total Stock Mkt Idx Inv2.60M3.16%-
Vanguard US Total Market Shares ETF818.82K2.23%-
Vanguard Institutional Extnd Mkt Idx Tr963.33K1.17%227.28K
Fidelity Advisor Biotechnology I883.08K1.08%-
iShares Russell 2000 Value ETF324.75K0.89%-
Fidelity Small Cap Index377.40K0.74%-15.86K
Vanguard Russell 2000 ETF180.62K0.49%1.64K

Recent Insider Transactions


DateNameRoleActivityValue
Jun 05, 2023Zoth Lota S.-Sell$3.19K
Mar 13, 2023Weiner David B.-Sell$6.71K
Feb 27, 2023Weiner David B.-Sell$14.94K
Aug 11, 2022Weiner David B. Sell$31.59K
Jul 20, 2022BENITO SIMON X Sell$4.50K

Insider Transactions Trends


DateBuySell
2026 Q2--
2026 Q1--
2025 Q2--
2025 Q1--
2024 Q4--

INO Ownership FAQ


Who Owns Inovio Pharmaceuticals?

Inovio Pharmaceuticals shareholders are primarily institutional investors at 4.94%, followed by 0.33% insiders and 94.73% retail investors. The average institutional ownership in Inovio Pharmaceuticals's industry, Biotech Stocks , is 49.09%, which Inovio Pharmaceuticals falls below.

Who owns the most shares of Inovio Pharmaceuticals?

Inovio Pharmaceuticals’s largest shareholders are Vanguard group (3.32M shares, 6.36%), Fmr (8.45M shares, 1.22%), and Janus henderson group (3.31M shares, 0.71%). Together, they hold 8.28% of Inovio Pharmaceuticals’s total shares outstanding.

Does Blackrock own Inovio Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Inovio Pharmaceuticals.

Who is Inovio Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Boxer capital management is Inovio Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.24% of its assets in 2.84M Inovio Pharmaceuticals shares, valued at 3.13M$.

Who is the top mutual fund holder of Inovio Pharmaceuticals shares?

Fidelity Small Cap Growth is the top mutual fund holder of Inovio Pharmaceuticals shares, with 6.85% of its total shares outstanding invested in 5.63M Inovio Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools